By a News Reporter-Staff News Editor at Biotech Business Week -- Advanced Cell Technology, Inc. ("ACT";OTCQB:ACTC), a leader in the field of regenerative medicine, announced that Chairman and CEO Gary Rabin will present a corporate overview at the 2013 Aegis Capital Healthcare Conference. The presentation will take place on Thursday, September 26 at 11 am PT at The Encore at Wynn Las Vegas in Las Vegas, NV. A question and answer session will follow Mr. Rabin's formal remarks (see also Advanced Cell Technology, Inc.).
Advanced Cell Technology CFO and Executive Vice President of Corporate Development, Ted Myles, will present at the StemCells & Regenerative Medicine Congress. The presentation will take place on Monday, September 30th at 11:40 am ET at the Hyatt Regency in Cambridge, MA. About Advanced Cell Technology, Inc.Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com or connect with the Company on Facebook, Twitter, LinkedIn, Google+, and YouTube. Forward-Looking Statements Statements in this news release regarding future financial and operating results, the relevance and applicability of clinical trials in animals to studying the effect of products in humans, future growth in animal and human research and development programs, potential new applications of and expanded indications covering our technology, the effects of donorless sources of stem cells on potency and the risk of communicable diseases in the manufacturing context, the existence and size of potential or existing market opportunities for the company, the effect of the company's products on the medical needs and quality of life of pets, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for and limited sources of future capital, failures or delays in obtaining regulatory approval of products, risks inherent in the development and commercialization of potential products, reliance on new and unproven technology in the development of products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the Quarterly Report on Form 10-Q for the three months ended June 30, 2013. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. There can be no assurance that the Company's clinical trials will be successful.
Keywords for this news article include: Advanced Cell Technology Inc..
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC